Jul 10, 2026 06:05AM
Jun 16, 2026 08:33AM
Jun 16, 2026 08:30AM
Jun 9, 2026 08:01AM
Jun 9, 2026 08:00AM
May 14, 2026 04:15PM
May 14, 2026 04:15PM Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
Apr 20, 2026 05:00PM
Apr 20, 2026 05:00PM
Mar 26, 2026 04:01PM
Mar 26, 2026 04:01PM
Mar 10, 2026 08:30AM
Feb 18, 2026 08:30AM
Feb 18, 2026 08:30AM Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Dec 1, 2025 05:51PM
Nov 13, 2025 04:00PM
Oct 14, 2025 04:30PM
Oct 6, 2025 08:30AM
Aug 14, 2025 08:30AM
Jul 29, 2025 08:32AM
Jul 29, 2025 08:30AM Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease
Jul 8, 2025 08:30AM
Jul 1, 2025 05:05PM
Jul 1, 2025 05:05PM
May 15, 2025 08:30AM
Apr 30, 2025 07:30AM
Apr 28, 2025 08:30AM
Apr 10, 2025 08:30AM Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens
Mar 18, 2025 08:30AM
Jan 8, 2025 08:32AM
Jan 8, 2025 08:30AM
Jan 6, 2025 08:30AM
Nov 15, 2024 05:00PM
Nov 12, 2024 09:22AM
Oct 15, 2024 08:30AM Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYLTM for Mild to Moderate Alzheimer’s Disease
Sep 24, 2024 05:16PM
Aug 19, 2024 08:30AM
Aug 12, 2024 04:35PM
Jul 29, 2024 08:08AM
May 14, 2024 07:24PM
Apr 3, 2024 10:08PM
Mar 1, 2024 07:53AM Alpha Cognition to Present at the Life Science Investor Forum March 7th
Feb 22, 2024 08:30AM
Feb 12, 2024 08:30AM
Dec 7, 2023 04:35PM
Nov 28, 2023 04:45PM
Sep 27, 2023 04:30PM
Aug 22, 2023 04:05PM
May 30, 2023 12:15PM Alpha Cognition Announces First Quarter 2023 Results and Provides Corporate Update
Mar 8, 2023 06:24PM

325,324 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All